You are on page 1of 1

Investors Eye

Stock Update

Jyothy Laboratories

Reco: Buy

Stock Update
CMP: Rs349

Growth drivers in place; retain Buy with revised PT of Rs400

Key points

Company details
5V

Price target:
Market cap:

5VFU

52-week high/low:

5V
ODNK

NSE volume:
1RRIVKDUHV
BSE code:



NSE code:

-<27+</$%

Sharekhan code:

-<27+</$%

)UHHRDW
1RRIVKDUHV

FU

Shareholding pattern

Others
10%
FIIs
14%
Domestic
institutions
9%

Promoters
67%

Price chart
370
350
330
310
290
270

Sep-16

May-16

Jan-16

Sep-15

250

Price performance

P

P

P P

$EVROXWH



  

5HODWLYH
WR6HQVH[





 

Key catalysts in place; growth momentum to sustain in near future:-\RWK\


/DERUDWRULHV -// KDVUHJLVWHUHGDGRXEOHGLJLWYROXPHJURZWK  LQWKH
ODVW WZR TXDUWHUV RQ WKH EDFN RI D VWURQJ SHUIRUPDQFH E\ VRPH RI LWV FRUH
FDWHJRULHV LQFOXGLQJ)DEULF&DUHDQG'LVKZDVK *RLQJDKHDGWKHNH\JURZWK
GULYHUVZLOOEH  DEHWWHUPRQVRRQ PRUHWKDQRI-//VUHYHQXHFRPHV
IURPUXUDO,QGLD DQG  VXVWHQDQFHRIVWURQJJURZWKPRPHQWXPLQFDWHJRULHV
VXFK DV 'LVKZDVK DQG GRXEOHGLJLW JURZWK LQ )DEULF &DUH RZLQJ WR UHQHZHG
LQLWLDWLYHV  7KHVH WZR FDWDO\VWV ZRXOG KHOS WKH FRPSDQ\ WR PDLQWDLQ 
YROXPHJURZWKLQWKHFRPLQJTXDUWHUV7KHFRPSDQ\H[SHFWVWKHSURWDELOLW\WR
LPSURYHJUDGXDOO\RQWKHEDFNRIDEHWWHUUHYHQXHPL[DQGHQKDQFHGRSHUDWLQJ
HIFLHQFLHV
Maxo likely to regain double-digit growth in Q2FY2017; Exo & Ujala also
expected to do well: 'HOD\ LQ WKH DUULYDO RI PRQVRRQ DIIHFWHG WKH RYHUDOO
SHUIRUPDQFHRIWKH0RVTXLWR5HSHOODQWFDWHJRU\LQWKH)0&*VSDFH+RZHYHU
EHWWHUPRQVRRQUDLQVLQ-XO\$XJXVWDQGQRZLQ6HSWHPEHUFRXSOHGZLWKWKH
ULVHLQHSLGHPLFVVXFKDV&KLNXQJXQ\D 'HQJXHKDYHUHYLYHGKRSHVRIEHWWHU
SHUIRUPDQFHE\WKLVFDWHJRU\LQWKHFRPLQJTXDUWHUV:LWK0D[ROLTXLGYDSRUL]HU
DQG0D[RPDJLFFDUGJDLQLQJJRRGDFFHSWDQFHZHH[SHFWUHYHQXHJURZWKLQWKLV
FDWHJRU\WRLPSURYHIURP4)<$QHZPHGLDFRPPXQLFDWLRQKHOSHG8MDOD
IDEULFZKLWHQHUWRDFKLHYHDYROXPHJURZWKRIaLQ4)< YHUVXVDWWLVK
FDWHJRU\JURZWK 7KLVWUHQGLVH[SHFWHGWRVXVWDLQLQWKHFRPLQJTXDUWHUVDV
ZHOO
Better working capital management; balance sheet is relatively comfortable:
-//LVIRFXVLQJRQEHWWHUZRUNLQJFDSLWDOPDQDJHPHQWDQGPDQDJHGWRLPSURYH
LWVRSHUDWLQJFDVKF\FOHWRDERXWGD\VLQ)<IURPGD\VLQ)<7KH
UHGHPSWLRQRI1&'LVH[SHFWHGWREHGRQHWKURXJKDPL[RILQWHUQDODFFUXDOV
DQGVDOHRIQRQFRUHDVVHWVUDLVLQJIXQGWKURXJKGHEWLQWKHFRPLQJTXDUWHUV
:HKDYHDVVXPHGIXQGUDLVLQJWKURXJKGHEWDQGKDYHDOUHDG\IDFWRUHGLQLQWHUHVW
FRVWIRU)<DQG)<'HVSLWHWKHOLNHO\UDLVLQJRIIXQGWKURXJKGHEWWKH
FRPSDQ\VGHEWHTXLW\ '( UDWLRZLOOEHFRPIRUWDEOHDWa[LQ)<:H
H[SHFW-//WRUHSD\GHEWE\WKHHQGRI)<WKURXJKEHWWHUFDVKRZV
Retain Buy with revised PT of Rs400: :LWKPXOWLSOHJURZWKGULYHUVLQSODFHZH
H[SHFW-//HDUQLQJVWRJURZVLJQLFDQWO\RYHUWKHQH[W\HDUV-//VVWRFNSULFH
KDVULVHQE\LQWKHODVWRQHPRQWKGXHWRDVWURQJRSHUDWLQJSHUIRUPDQFH
LQ4)<7KHVWRFNLVFXUUHQWO\WUDGLQJDW[LWV)<(HDUQLQJVZKLFK
LVDWDGLVFRXQWWRVRPHRIWKHODUJHDQGPLGFDS)0&*VWRFNV WUDGLQJDWa[
)<(HDUQLQJV 7KHUHIRUHLQYLHZRIEHWWHUJURZWKSURVSHFWVDQGUHODWLYHO\
EHWWHUYDOXDWLRQVZHPDLQWDLQRXU%X\UHFRPPHQGDWLRQRQWKHVWRFNZLWKD
UHYLVHGSULFHWDUJHW 37 RI5V UROOLQJRYHU37WR)<)<(HDUQLQJV 
Valuations (Consolidated)
Particulars
1HWVDOHV
2SHUDWLQJSURW
$GMXVWHG3$7
(36 5V
230 
3( ;
(9(%,'7$ ;
5R( 
5R&( 

FY2015










FY2016*










FY2017E










FY2018E










Rs cr
FY2019E










UHVWDWHGQDQFLDOVGXHWRFKDQJHLQDFFRXQWLQJVWDQGDUGVWR,1'$6

Sharekhan

September 20, 2016

Home

Next

You might also like